Just as the younger age and lower comorbidity burden likely explain the more pronounced reduction in all-cause mortality observed among younger individuals, these same factors may also account for their significantly lower risk of the composite outcomecomprising acute and chronic pancreatitiscompared with older participants, who instead exhibited an increased risk
Results vary and do not prove weight-loss effectiveness
The strategies involved producing formulations of DPP-4-resistant GLP-1 receptor activators
More than 20 other states also have taken steps to implement bans on certain dyes from schools some bans to take effect as early as this year
Actualmente estos medicamentos se manejan para la obesidad y para las personas que tienen sobrepeso con alguna otra enfermedad de base como hipertensin, diabetes y colesterol alto, segn la Administracin de Alimentos y Medicamentos (FDA, por sus siglas en ingls)
Schmidt-Sommerfeld E, Penn D